Cure51 capta 15 millones de euros en una ronda semilla para desarrollar tratamientos innovadores contra el cáncer

by Professional Newco

Cure51, empresa de biotecnología que investiga los mecanismos biológicos responsables de la supervivencia en pacientes con cáncer de alto riesgo, ha recaudado 15 millones de euros en una ronda de f...

Read more

Gradient Denervation Technologies closes €14m Series A led by Sabadell Asabys

by Asabys Partners

Asabys Partners led the round through its new fund Sabadell Asabys II and was joined by Thuja Capital and founding investor Sofinnova Partners. Gradient was established in 2020 through a €3.5m seed ...

Read more

Nuage Therapeutics raises €12M in Seed Financing led by Sofinnova Partners and Asabys

by Asabys Partners

The financing round was led by Sofinnova Partners, a leading European venture capital firm in life sciences, and Asabys, a venture capital firm based in Barcelona and specialized in the healthcare sec...

Read more

Axon reinforces its leadership in the Life Sciences sector with 2 new investments: Forbion & Sofinnova Partners

by Axon Partners Group

Aurora has already committed to five Life Sciences funds, with current exposure in the portfolio over 45%. The new investments are a strong fit for the overall fund strategy as they are with top-perfo...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Miura Partners' Impact Fund acquires a 2...

by Miura Partners

Bianna, a leading multinational in engineering, design, manufacturing,...

Photos Stream